Search research articles
Contact Us
Filters
Showing results (131-140 of 170) with videos related to
Page
of 17
Sort By:
Scientific Reports
|
November 21, 2019
Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition
Michael Vacher, Tenielle Porter, Victor L Villemagne, et al.
Brain Communications
|
September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Samantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort
Ester Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Frontiers in Aging Neuroscience
|
December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
Samantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
Yen Ying Lim, Paul Maruff, Naoki Kaneko, et al.
Biomedicines
|
May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
Kunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
Victor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 28, 2017
A Novel Approach to Identifying a Neuroimaging Biomarker for Patients With Serious Mental Illness
Alok Madan, J Christopher Fowler, Michelle A Patriquin, et al.
Neurobiology of Aging
|
October 6, 2023
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease
Ying Xia, Paul Maruff, Vincent Doré, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 170) with videos related to
Sort By:
Page
of 17
Scientific Reports
|
November 21, 2019
Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition
Michael Vacher, Tenielle Porter, Victor L Villemagne, et al.
Brain Communications
|
September 21, 2020
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Samantha C Burnham, Noelia Fandos, Christopher Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort
Ester Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Frontiers in Aging Neuroscience
|
December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
Samantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
Yen Ying Lim, Paul Maruff, Naoki Kaneko, et al.
Biomedicines
|
May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
Kunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
Victor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 28, 2017
A Novel Approach to Identifying a Neuroimaging Biomarker for Patients With Serious Mental Illness
Alok Madan, J Christopher Fowler, Michelle A Patriquin, et al.
Neurobiology of Aging
|
October 6, 2023
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease
Ying Xia, Paul Maruff, Vincent Doré, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Page
of 17